South Korea And Australia On The Rise As Clinical Research Hubs

By Akosua Mireku

Dr. Yooni Kim, Vice President of Clinical Services at Novotech, highlighted Australia and South Korea as burgeoning hubs for clinical research in the Asia-Pacific region during a recent conference.

Specifically, she underscored the attractiveness of South Korea's government frameworks, including its national AI platform for clinical trials, and praised Australia's streamlined trial start-up timeline and regulatory environment, making it an appealing destination for biotech companies seeking to advance their clinical programs globally.